Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of pluripotent stem cell-derived mesenchymal stem cells in treatment of psoriasis

A technology of pluripotent stem cells and mesenchymal stem cells, applied in the application field of mesenchymal stem cells in the treatment of psoriasis, can solve the problems of donor injury, MSCs difficult to standardize, and hinder the clinical treatment of MSCs

Pending Publication Date: 2022-05-17
XIAMEN UNIV +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, MSCs can be derived from a variety of tissues including bone marrow, umbilical cord, placenta, and fat. However, there are several major problems with MSCs used in clinical trials and treatments: 1. The demand for cells is huge; 2. Suitable donors are required and may be lost. 3. There may be heterogeneity in MSCs from different sources; 4. It is difficult to standardize MSCs from different sources. These problems seriously hinder the clinical treatment of MSCs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pluripotent stem cell-derived mesenchymal stem cells in treatment of psoriasis
  • Application of pluripotent stem cell-derived mesenchymal stem cells in treatment of psoriasis
  • Application of pluripotent stem cell-derived mesenchymal stem cells in treatment of psoriasis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Psoriasis repair with MSCs derived from hESCs.

[0040] 1. Obtain MSCs derived from hESC:

[0041] The hESC cell line H9 was differentiated into MSCs (differentiation medium: K-DMEM + 10% KSR + 0.5% PSG + 0.5% NAA + 8ng / ml bFGF + 4ng / ml PDGF + 1% ITS), by flow cytometry The surface markers CD105, CD90, and CD29 specifically expressed by MSCs were identified to determine the differentiation efficiency of hESCs to MSCs, and their biological characteristics were identified through adipogenic and osteogenic differentiation.

[0042] Morphological observation of H9 embryonic stem cells see figure 1 , hESCs cultured in the feeder-free system grow like clones, with good light transmission, cells in the clones are tightly arranged, and the ratio of nucleoplasm to cytoplasm is high. After being induced to differentiate into MSCs, the cell morphology was as follows figure 2 As shown, it becomes a long fusiform. Through flow cytometric analysis, it was found that hESC-MSCs hi...

Embodiment 2

[0053] Inject hESC-derived MSCs.

[0054] Injection of hESC-derived MSCs may also have similar effects, but the route of treatment is harmful.

[0055] The mice used to establish the mouse psoriasis model were purchased from (Xiamen University Experimental Animal Center). The back hair of the mice was shaved off, and 5% imiquimod (Imiqumod, IMO) ointment was applied daily to create a mouse psoriasis model. All the mice were housed in IVC independent cages, with normal diet and water.

[0056] Treatment began on the day of modeling, and hESC-derived MSCs were injected subcutaneously into the damaged skin every day, and the wound healing was observed on the 7th day.

[0057] Such as Figure 7 As shown, the 7-day corrected PASI score of the MSC-injected treatment group was 5.00±0.47, which was significantly better than that of the control group.

Embodiment 3

[0059] Psoriasis repair with hiPSC-derived MSCs.

[0060] 1. Obtain hiPSC-derived MSCs:

[0061] hiPSCs are cells obtained from healthy people and prepared according to the method reported in the article by Shinya Yamanaka et al. (Cell, 2007, 131, 861-872).

[0062] The hiPSC cells were differentiated into MSCs (differentiation medium: K-DMEM+10% KSR+0.5% PSG+0.5% NAA+8ng / ml bFGF+4ng / ml PDGF+1%ITS).

[0063] The result is as image 3 As shown, the differentiated MSCs have the typical morphological characteristics of MSCs, which are long spindle-shaped and closely arranged cells.

[0064] 2. Establish a mouse skin psoriasis model:

[0065] The mice used to establish the mouse psoriasis model were purchased from (Xiamen University Experimental Animal Center). The back hair of the mice was removed, and imiquimod (Imiqumod, IMO) was applied daily to create a psoriasis model, (the mice were all kept in IVC independent mouse cages, with normal diet and water supply)

[0066] 3....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an application of human pluripotent stem cell-derived mesenchymal stem cells (MSCs) in treatment of psoriasis.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to the application of mesenchymal stem cells (MSCs) derived from pluripotent stem cells in the treatment of psoriasis. Background technique [0002] Psoriasis is a chronic inflammatory skin disease characterized by skin erythema and scales. The pathological features include neovascularization, inflammatory response, and abnormal proliferation of epidermal cells. Some patients have more or less itchy skin symptoms. Due to the long course of the disease, it is easy to recur, and the treatment difficulty coefficient is high, which not only damages the health of the patient, but also seriously affects the social life, work and life of the patient. The treatment of psoriasis generally adopts external drugs / physiotherapy plus internal drugs, including physical light therapy, anti-infective drugs, biological agents, and regulatory immunotherapy. The pathogenesis of psoriasis is co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/28A61K9/06A61P17/06A61K8/99A61K8/04A61Q19/00
CPCA61K35/28A61K9/06A61P17/06A61K8/99A61K8/042A61Q19/00A61K2800/10
Inventor 徐秀琴刘乐锋刘靖
Owner XIAMEN UNIV